Sex | Age at diagnosis | Year of diagnosis | Site/type of cancer | No. cancer | Confirmation | Presentation |
F† | 15 | 1977 | Jejunal adenocarcinoma | 1 | HI | C/O |
F | 16 | 1998 | Malignant Sertoli cell tumour ovary | 1a | HI | C/O |
M† | 16 | 1962 | Small intestinal adenocarcinoma | 1b | HI | C/O |
F* | 26 | 2008 | Gastric adenocarcinoma | 2a | HI | SV |
M | 29 | 1992 | Liposarcoma | 1c | HI | C/O |
F | 30 | 2005 | Melanoma | 1 | MR | C/O |
F | 30 | 1999 | Ovarian small cell carcinoma | 1 | HI | C/O |
M | 30 | 1979 | Gastric adenocarcinoma | 1 | HI | C/O |
M* | 30 | 2004 | Colorectal adenocarcinoma | 1 | HI | SV |
M | 31 | 1947‡ | Adenocarcinoma digestive tract | 1 | MR1 25 26 | C/O |
M | 33 | 1953‡ | Seminoma of testis | 1 | HI | C/O |
F | 35 | 1994 | Cervical adenoma malignum | 1 | HI | SV |
F | 35 | 1987 | Pancreatic adenocarcinoma | 1 | HI | C/O |
M | 35 | 1998 | Adenocarcinoma digestive tract | 1 | HI | C/O |
F | 36 | 1997 | Adenocarcinoma digestive tract | 1 | HI | C/O |
F | 37 | 2004 | Malignant Sertoli cell tumour ovary | 1 | HI | C/O |
F | 37 | 1996 | Colorectal adenocarcinoma | 1d | HI | SV |
F | 40 | 1937‡ | Colorectal adenocarcinoma | 1 | MR1 25 26 | C/O |
M | 41 | 2000 | Ampullary adenocarcinoma | 1 | HI | C/O |
M | 43 | 1975 | Colorectal adenocarcinoma | 1 | HI | C/O |
F | 45 | 2005 | Broncheo-alveolar carcinoma | 1 | HI | C/O |
F | 45 | 1996 | Broncheo-alveolar carcinoma | 1 | HI | C/O |
F | 45 | 1960 | Cervical carcinoma | 1 | AN | C/O |
M | 45 | 2008 | Pancreatic acinar cell carcinoma | 2c | HI | C/O |
F | 46 | 1944‡ | Breast carcinoma | 1 | MR1 25 26 | C/O |
F | 48 | 2002 | Pulmonary adenocarcinoma | 1 | HI | C/O |
M | 48 | 2001 | Non-Hodgkin's lymphoma (B-cell) | 1e | HI | C/O |
F | 49 | 2009 | Breast carcinoma | 2d | HI | C/O |
F* | 49 | 2008 | Gastric adenocarcinoma | 1 | HI | SV |
F | 51 | 1998 | Melanoma | 1 | MR | C/O |
F | 51 | 1977 | Squamous cell carcinoma of paranasal sinus | 1 | HI | C/O |
M | 51 | 2004 | Pulmonary adenocarcinoma | 1 | HI | C/O |
M | 52 | 2001 | Adenocarcinoma, unknown primary origin | 1 | HI | C/O |
F | 53 | 1964 | Breast carcinoma | 1 | AN | C/O |
M | 53 | 2006 | Ampullary adenocarcinoma | 2e | HI | C/O |
M | 54 | 2004 | Ampullary adenocarcinoma | 1 | HI | C/O |
M | 54 | 1980 | Jejunal adenocarcinoma | 1 | MR | C/O |
F | 55 | 2009 | Breast carcinoma | 1 | MR | C/O |
M | 57 | 2006 | Biliary adenocarcinoma | 1 | HI | C/O |
M | 57 | 2004 | Adenocarcinoma, unknown primary origin | 2b | HI | C/O |
F | 61 | 2006 | Breast carcinoma | 1 | HI | SV |
F | 61 | 1996 | Breast carcinoma | 1 | HI | C/O |
F | 61 | 1988 | Colorectal adenocarcinoma | 1f | HI | C/O |
M | 61 | 1933‡ | Gastric adenocarcinoma | 1 | MR1 25 26 | C/O |
M | 64 | 1996 | Colorectal adenocarcinoma | 1g | HI | C/O |
M | 66 | 1998 | Pancreatic adenocarcinoma | 2g | HI | C/O |
F | 72 | 1999 | Cervical adenoma malignum | 2f | HI | C/O |
F | 73 | 2008 | Biliary adenocarcinoma | 1 | HI | C/O |
M | 76 | 1937‡ | Colorectal adenocarcinoma | 1 | MR1 25 26 | C/O |
↵* Carcinoma in situ.
↵† No revision to rule out pseudo-invasion.
↵‡ Diagnosed before 1960, hence not included in relative cancer risk analysis.
AN, Anamnestic; C/O, Complaints/Other; diagn., cancer diagnosis; F, Female; HI, histology; M, male; MR, medical record; No, number; SV, surveillance.
1 25 26=malignancies confirmed by previous reports, see references.
a–gpatients with two primary cancers; asame patient; bsame patient; csame patient; dsame patient; esame patient; fsame patient; gsame patient.